Tuberculosis, HIV and the developing world

Clinical Medicine

Volumn 1, Issue 1, 2001, Pages 62-68

  Gazzard, Brian ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; DIDANOSINE; STREPTOMYCIN; ZALCITABINE; ZIDOVUDINE;

ARTICLE; COMBINATION CHEMOTHERAPY; COMORBIDITY; CYTOKINE RELEASE; DEVELOPING COUNTRY; DISEASE PREDISPOSITION; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOLOGY; INFECTION CONTROL; PATIENT COMPLIANCE; PUBLIC HEALTH; SERODIAGNOSIS; TUBERCULOSIS;

EID: 0035043404     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.1-1-62     Document Type: Article

References (2)

1. Medical Research Council. Treatment of pulmonary tuberculosis with streptomycin and para-amino-salicylic acid. Br Med J 1950;ii:1073-85.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.